8/6/2013 7:01:45 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
After two drug industry suitors already won lower tax rates through Irish acquisitions, investors are speculating Jazz Pharmaceuticals Plc (JAZZ) and Alkermes Plc (ALKS) may draw the next bids. Elan Corp. and Warner Chilcott Plc (WCRX), drug companies both domiciled in Ireland, this year found buyers motivated in part to cut their tax bill. The latest agreement, Perrigo Co. (PRGO)’s purchase of Elan announced July 29, helped drive shares of Jazz and Alkermes to a record and 12-year high, respectively, according to data compiled by Bloomberg.
Help employers find you! Check out all the jobs and post your resume.
comments powered by